MYCN-related suppression of functional CD44 expression enhances tumorigenic properties of human neuroblastoma cells

被引:25
|
作者
Gross, N [1 ]
Bourloud, KB [1 ]
Brognara, CB [1 ]
机构
[1] Univ Hosp, CHUV, Dept Pediat, Oncohematol Unit, CH-1011 Lausanne, Switzerland
关键词
neuroblastoma; CD44; MYCN; adhesion; tumor growth;
D O I
10.1006/excr.2000.5007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Highly malignant neuroblastoma tumors with MYCN amplification have been shown to downregulate the expression of the CD44 adhesion receptor. We have previously shown that MYCN amplified neuroblastoma cell lines either lack CD44 expression or express a nonfunctional, nonhyaluronic acid binding CD44 receptor. By analysis of cells with manipulated expression of either CD44 or MYCN, we demonstrate that transfection of cells with a CD44 full-length cDNA construct produced a functional receptor in single copy MYCN cells and a nonfunctional CD44 receptor in MYCN amplified cells, similar to the CD44 receptor expressed by cells with enforced MYCN. Analysis of the in vivo growth properties of the transfectants revealed that the restoration of a functional CD44 receptor in nonamplified cells resulted in the suppression of in vivo cell growth, therefore linking the MYCN-related lack of hyaluronic acid-binding function of CD44 to the highly tumorigenic properties of a subset of neuroblastoma cells. (C) 2000 Academic Press.
引用
收藏
页码:396 / 403
页数:8
相关论文
共 50 条
  • [41] Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man?
    Fillmore, Christine
    Kuperwasser, Charlotte
    BREAST CANCER RESEARCH, 2007, 9 (03)
  • [42] CD44 and TGFβ1 synergise to induce expression of a functional NADPH oxidase in promyelocytic cells
    Basoni, C
    Reuzeau, E
    Croft, D
    Génot, E
    Kramer, IM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 343 (02) : 609 - 616
  • [43] Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man?
    Christine Fillmore
    Charlotte Kuperwasser
    Breast Cancer Research, 9
  • [44] EXPRESSION OF A HUMAN HOMING RECEPTOR (CD44) IN LYMPHOID MALIGNANCIES AND RELATED STAGES OF LYMPHOID DEVELOPMENT
    HORST, E
    MEIJER, CJLM
    RADASKIEWICZ, T
    VANDONGEN, JJM
    PIETERS, R
    FIGDOR, CG
    HOOFTMAN, A
    PALS, ST
    LEUKEMIA, 1990, 4 (05) : 383 - 389
  • [45] EXPRESSION OF CD44 VARIANT PROTEINS IN HUMAN COLORECTAL-CANCER IS RELATED TO TUMOR PROGRESSION
    WIELENGA, VJM
    HEIDER, KH
    OFFERHAUS, GJA
    ADOLF, GR
    VANDENBERG, FM
    PONTA, H
    HERRLICH, P
    PALS, ST
    CANCER RESEARCH, 1993, 53 (20) : 4754 - 4756
  • [46] Correlation of CD44 expression with proliferative activity of normal human breast epithelial cells in culture
    Cooper, NL
    Bardy, P
    Bacani, J
    Kuusk, U
    Dougherty, GJ
    Eaves, CJ
    Emerman, JT
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 50 (02) : 143 - 153
  • [47] IL-6 regulates CD44 cell surface expression on human myeloma cells
    T Vincent
    N Mechti
    Leukemia, 2004, 18 : 967 - 975
  • [48] Expression of hyaluronan-recogizing isoform of CD44 by human and murine mast cells.
    Whittlesey, K
    Dastych, J
    Metcalfe, DD
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 376 - 376
  • [49] IL-6 regulates CD44 cell surface expression on human myeloma cells
    Vincent, T
    Mechti, N
    LEUKEMIA, 2004, 18 (05) : 967 - 975
  • [50] Correlation of CD44 expression with proliferative activity of normal human breast epithelial cells in culture
    Nancy L. Cooper
    Peter Bardy
    Julinor Bacani
    Urve Kuusk
    Graeme J. Dougherty
    Connie J. Eaves
    Joanne T. Emerman
    Breast Cancer Research and Treatment, 1998, 50 : 143 - 153